HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
about
Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting AntiviralsFrailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.Drinking motives among HIV primary care patients.Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era.HIV/HCV Co-infection, Liver Disease Progression, and Age-Related IGF-1 DeclineHepatitis C virus infection in the human immunodeficiency virus infected patient.Age and ethnicity in cirrhosis.HIV-1 Infection Accelerates Age According to the Epigenetic Clock.The relationship of physical performance with HIV disease and mortality.Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsHIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients.Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV.Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders.Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus CoinfectionManagement of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.HCV treatment in children and young adults with HIV/HCV co-infection in Europe.CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentHuman immunodeficiency virus and liver disease forum 2012.Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals.The rapid evolution of treatment strategies for hepatitis C.High Hepatitis C cure rates among black and non-black HIV-infected adults in an urban center.Management of HCV in cirrhosis-a rapidly evolving landscape.Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.Aging of the Liver: What This Means for Patients with HIV.Hemophilia Liver Transplantation Observational Study.Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.HIV infection duration, social support and the level of trauma symptoms in a sample of HIV-positive Polish individuals.Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.Hepatitis C in African Americans.Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide
P2860
Q27025083-2B44FADF-E9AF-492F-A0EB-C472A9D992A8Q28073489-F5DB76D0-F0DF-4423-BCD2-E22F11EF5BBCQ30248351-E5D4749F-729D-4534-A071-D7E5B0A2474DQ30577310-C5F8E0CA-220F-4CB6-A33F-E3A861D8D945Q33629538-3EB9D6C4-9FBE-4AF0-96FD-9367E40C29C8Q33657640-FEE9B801-6791-4995-85CC-C314C15E8450Q34168504-DB7D0E4E-B810-4554-B8F9-2458AFED47C7Q34231825-5EB6EAF1-0F48-4FD2-9204-392A232F0B41Q34476144-57281398-37E5-4247-8B21-2786AEB987B0Q35234602-4C3F0692-DD16-4120-A98D-FE260D61C3E1Q35904838-115D3AB1-EAFE-467F-88D7-DCEE18C63C60Q35952818-35B9078D-6C0B-4189-9E1D-94BC2F1F41F5Q36035679-A41E22F8-341A-4EF9-AC45-77EFDE68AEFFQ36327795-270ADA65-AAF4-4014-B900-B3E501E07E16Q36330435-925F9CA7-B843-4132-ACB9-9A57BBC7DF62Q36910855-188B6E0B-BD26-4020-B93E-DC9763B66B32Q36967076-849894B9-06DF-43CD-9427-C52A528F0B24Q36989549-A0BC3267-2EF6-4907-8291-5C0E156CCC7AQ37003049-31437E0E-195D-493A-90B4-9C457D778AC7Q37055228-6D7CDB13-5DC8-4440-A4C2-AA7BB2B3D113Q37098372-8D26EA70-8844-440C-A7D8-59CF80125C1DQ37100669-1DB3794D-3291-4F74-83FE-F72B51461ED6Q37361082-D111F147-A980-4179-8E6C-4278BF62C53CQ37834503-9730615C-8A3D-4697-A032-B3B54287C611Q38204657-6714D2D1-98AE-424C-8CB0-5593126B2271Q38401928-97EA295C-9506-44AC-9F29-764C3B5F3097Q38432047-F3FF9105-563F-4CBC-A45B-5B75996286C6Q38623266-F04825EC-8105-416F-BCEA-E260DDB77AF1Q38936312-93602B20-956E-4B80-96EA-3FB5D4E63188Q39115852-5C4D419B-3B9E-4620-BA9D-F1CD17E1B6C8Q39237702-1B2644EF-333F-44F0-B21E-88F73FC29AE7Q40092669-BE9AD5A6-7F14-466E-872D-D372FD352324Q40280432-C9EACE37-81AF-4572-AEA7-6DEE390DFECBQ40390697-BB2969F3-9C71-4DB0-B19D-1F49064AA2EEQ40399713-F1A85E7C-5513-41D0-9878-0EA66E89F8C7Q40750320-9D0EB64A-C0E7-42DF-B86D-044E4E740616Q41710649-E4A9D775-41DC-4266-B4F5-02991610E20AQ41733883-D991165E-7EA7-4CEF-8B33-D3D52D8D917DQ41758808-9E3030C7-4009-4728-8D51-B4027365F223Q41925730-50EB92F7-7B7C-42B5-B435-C5B533C294E9
P2860
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
@en
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
@nl
type
label
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
@en
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
@nl
prefLabel
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
@en
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
@nl
P2093
P2860
P1476
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
@en
P2093
Ashwin Balagopal
David L Thomas
Gregory D Kirk
Jacquie Astemborski
Jonathan Washington
Noya Galai
Shruti H Mehta
Yvonne Higgins
P2860
P304
P356
10.7326/0003-4819-158-9-201305070-00604
P407
P577
2013-05-01T00:00:00Z